Drug Class
anti-amyloid beta monoclonal antibody
Type
brand
Active Ingredient
lecanemab
📋Overview
Leqembi is a medication developed for the management of Alzheimer's disease. It is designed to target and reduce amyloid plaques in the brain, which are thought to play a role in the progression of this neurodegenerative condition. Leqembi is associated with use in adults experiencing mild cognitive impairment or mild dementia due to Alzheimer's disease. Its approval represents a recent advancement in therapies aimed at modifying the underlying disease process.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Leqembi
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.